Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uhi Toh

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Surgery Today|January 8, 2014
Primary breast peripheral T-cell lymphoma not otherwise specified: report of a caseDaisuke Muroya, Uhi Toh, Nobutaka Iwakuma, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2008
[Conventional chemotherapy combined with the repetitive immune cell transfer for patients with refractory advanced gastric cancer]Uhi Toh, Teruhiko Fujii, Mai Mishima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 24, 2020
[Triple-Tracer Technique of Sentinel Lymph Node Biopsy Using Blue Dye plus Radioisotope Combined with Real-Time Indocyanine Green(ICG)Fluorescence Imaging Procedures for Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy]Yuko Takao, Uhi Toh, Sayaka Sakurai, et al.
Breast Cancer (Tokyo, Japan)|January 29, 2008
Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancerTeruhiko Fujii, Goro Yokoyama, Hiroki Takahashi, et al.
Anticancer Research|July 27, 2022
Efficacy and Safety of Monthly Minodronate Therapy in Postmenopausal Breast Cancer Patients Receiving Aromatase InhibitorsNanae Ogata, Uhi Toh, Tomoya Sudou, et al.
Annals of the New York Academy of Sciences|December 31, 2005
The proteasome inhibitor bortezomib (Velcade) sensitizes some human tumor cells to Apo2L/TRAIL-mediated apoptosisAlan D Brooks, Teresa Ramirez, Uhi Toh, et al.
Surgery Today|February 2, 2008
Adenomyoepithelioma of the breast diagnosed by a mammotome biopsy: report of a caseToshiro Yahara, Rin Yamaguchi, Goro Yokoyama, et al.
Nuclear Medicine Communications|April 27, 2013
The relationship between 18F-FDG metabolic volumetric parameters and clinicopathological factors of breast cancerHayato Kaida, Uhi Toh, Masanobu Hayakawa, et al.
European Journal of Preventive Cardiology|June 23, 2023
Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insightsTatsuhiro Shibata, Shoichiro Nohara, Nagisa Morikawa, et al.
Breast Cancer (Tokyo, Japan)|July 6, 2013
Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium in metastatic and recurrent breast cancerHiroko Otsuka, Teruhiko Fujii, Uhi Toh, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Surgery Today|January 8, 2014
Primary breast peripheral T-cell lymphoma not otherwise specified: report of a caseDaisuke Muroya, Uhi Toh, Nobutaka Iwakuma, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2008
[Conventional chemotherapy combined with the repetitive immune cell transfer for patients with refractory advanced gastric cancer]Uhi Toh, Teruhiko Fujii, Mai Mishima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 24, 2020
[Triple-Tracer Technique of Sentinel Lymph Node Biopsy Using Blue Dye plus Radioisotope Combined with Real-Time Indocyanine Green(ICG)Fluorescence Imaging Procedures for Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy]Yuko Takao, Uhi Toh, Sayaka Sakurai, et al.
Breast Cancer (Tokyo, Japan)|January 29, 2008
Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancerTeruhiko Fujii, Goro Yokoyama, Hiroki Takahashi, et al.
Anticancer Research|July 27, 2022
Efficacy and Safety of Monthly Minodronate Therapy in Postmenopausal Breast Cancer Patients Receiving Aromatase InhibitorsNanae Ogata, Uhi Toh, Tomoya Sudou, et al.
Annals of the New York Academy of Sciences|December 31, 2005
The proteasome inhibitor bortezomib (Velcade) sensitizes some human tumor cells to Apo2L/TRAIL-mediated apoptosisAlan D Brooks, Teresa Ramirez, Uhi Toh, et al.
Surgery Today|February 2, 2008
Adenomyoepithelioma of the breast diagnosed by a mammotome biopsy: report of a caseToshiro Yahara, Rin Yamaguchi, Goro Yokoyama, et al.
Nuclear Medicine Communications|April 27, 2013
The relationship between 18F-FDG metabolic volumetric parameters and clinicopathological factors of breast cancerHayato Kaida, Uhi Toh, Masanobu Hayakawa, et al.
European Journal of Preventive Cardiology|June 23, 2023
Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insightsTatsuhiro Shibata, Shoichiro Nohara, Nagisa Morikawa, et al.
Breast Cancer (Tokyo, Japan)|July 6, 2013
Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium in metastatic and recurrent breast cancerHiroko Otsuka, Teruhiko Fujii, Uhi Toh, et al.
Pageof 7